Congressional Leaders To Consider “Emergency Legislation” In Wake Of Heparin Safety Scare

Congressional leaders have ratcheted up the heat on U.S. FDA and Baxter Healthcare over their handling of the heparin safety scare, alleging that the agency has abandoned its policy to conduct preapproval inspections of API suppliers and saying they would consider introducing "emergency legislation" to mandate such inspections

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip